What You Need to Know Ahead of Revvity’s Earnings Release As Revvity gears up to reveal its second-quarter earnings report soon, analysts forecast single-digit profit growth. Barchart · Jul 3
Is Revvity Stock Underperforming the Nasdaq? Revvity has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects. Barchart · Jun 19
Is Revvity Stock Underperforming the S&P 500? Revvity has lagged the broader S&P 500 over the past year, though analysts maintain a cautiously positive outlook on its forward growth potential. Barchart · Mar 20
Do Wall Street Analysts Like Revvity Stock? Although Revvity has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects. Barchart · Feb 23
What to Expect From Revvity’s Q4 2025 Earnings Report Revvity is set to announce its fourth-quarter results soon, and analysts expect a single-digit rise in its adjusted earnings per share. Barchart · Jan 5
How Is Revvity's Stock Performance Compared to Other Health Care Stocks? Revvity has underperformed the Health Care industry over the past year, but analysts are moderately optimistic about the stock’s prospects. Barchart · Dec 15, 2025
Revvity Analysts Increase Their Forecasts After Q3 Earnings Revvity, Inc. (NYSE:RVTY) announced mixed third-quarter 2025 financial results on Monday. Benzinga · Oct 28, 2025
Revvity Lifts Profit Outlook, Launches $1 Billion Buyback Plan Revvity, Inc. (NYSE:RVTY) announced its third-quarter 2025 financial results on Monday. The company’s performance was mixed compared to analyst expectations, and the stock declined immediately. Benzinga · Oct 27, 2025
Here's What to Expect From Revvity's Next Earnings Report Healthcare major Revvity is set to announce its third-quarter results in the upcoming weeks, and analysts expect a notable double-digit drop in earnings. Barchart · Oct 16, 2025
Revvity Stock: Is RVTY Underperforming the Healthcare Sector? Despite Revvity’s weak performance relative to the healthcare sector, Wall Street analysts remain moderately optimistic about the stock’s prospects. Barchart · Sep 23, 2025
Are Wall Street Analysts Predicting Revvity Stock Will Climb or Sink? Diagnostics company Revvity has been underperforming the broader market. Are analysts still bullish about its stock? Barchart · Aug 29, 2025
Revvity Slashes Outlook As China Policy Deals Diagnostics Blow Revvity Inc. (NYSE:RVTY) stock is trading lower on Monday following the life science tools maker’s second-quarter 2025 earnings report, which also included a trimmed profit forecast for 2025. Benzinga · Jul 28, 2025
Earnings Preview: What to Expect From Revvity's Report Revvity is all set to release its fiscal second-quarter earnings later this month, and analysts project a single-digit earnings decline. Barchart · Jul 15, 2025
Is Wall Street Bullish or Bearish on Revvity Stock? Although Revvity has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. Barchart · May 22, 2025
Barchart · Apr 23, 2025 Revvity’s Quarterly Earnings Preview: What You Need to Know Revvity is gearing up to announce its first-quarter results later this month, and analysts expect a single-digit drop in earnings.
Barchart · Mar 28, 2025 Is Revvity Stock Underperforming the Nasdaq? Despite lagging behind the Nasdaq Composite over the past year, analysts remain bullish on Revvity’s prospects.
Barchart · Feb 21, 2025 Are Wall Street Analysts Bullish on Revvity Stock? Revvity has lagged behind the broader market this year, and Wall Street analysts maintain a cautiously optimistic outlook on its future potential.
Barchart · Dec 27, 2024 Is Revvity Stock Underperforming the S&P 500? Revvity has substantially lagged behind the S&P 500 over the past year, yet analysts remain bullish on the stock’s prospects.
Barchart · Nov 26, 2024 What Are Wall Street Analysts' Target Price for Revvity Stock? Revvity has underperformed the broader market this year, but Wall Street analysts remain somewhat optimistic about the stock's future prospects.
Barchart · Oct 21, 2024 Revvity Earnings Preview: What to Expect Revvity is set to release its third-quarter earnings next month, with analysts projecting a slight decline in profit.
Barchart · Sep 25, 2024 How Is Revvity's Stock Performance Compared to Other Diagnostics & Research Stocks? Despite Revvity’s underperformance compared to its industry peers over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Barchart · Aug 26, 2024 Revvity Stock: Is Wall Street Bullish or Bearish? Revvity has significantly underperformed the broader market this year, but Wall Street analysts are moderately optimistic about the stock’s prospects.
Barchart · Jul 23, 2024 What You Need to Know Ahead of Revvity’s Earnings Release Revvity will release its second-quarter earnings later this month, and analysts anticipate a single-digit profit dip.
Barchart · Jan 4, 2024 Stocks Finish Mostly Lower as Higher Bond Yields Undercut Tech Stocks What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.53%. Stocks on Thursday settled mixed, with the S&P...
Birmingham Post · Jun 26, 2023 Revenues and profits rise at Immunodiagnostic Systems in year after £110m takeover The Boldon company became part of American life sciences group Revvity two years ago